Male Contraceptive Initiative Supports the Launch of Plan A™ Male Birth Control
NEXT Life Sciences is announcing its partnership with Male Contraceptive Initiative, the largest 501(c)(3) non-profit in the world dedicated to advancing male contraception. This partnership includes a grant of $400K to NEXT to support clinical trial research toward Plan A™, being developed as a long-acting, non-hormonal, reversible contraceptive method.
Male birth control maker raises $2.5 million to develop “Plan A”
Next Life Sciences has raised $2.5 million to develop a male contraceptive product called Plan A, which could become a nonsurgical alternative to vasectomies.
Male contraceptive under development blocks sperm with quick injection, easily reversible
Vasectomies and condoms have traditionally been the only ways men can use contraception, but a Los Angeles-based health startup wants to change that.
The Family Leads NEXT Life Sciences $2.5 Million Funding Round for Plan A Male Birth Control
Ryan Breslow joins as a Strategic Advisor to bring male birth control to market.
Bolt’s Ryan Breslow Is Backing This Male Birth Control Startup
The startup just raised a $2.5 million seed round led by Bolt cofounder Ryan Breslow's VC firm. NEXT wants to start clinical trials this year, and says its birth control could be ready by 2026.
StartUp Health Insights: Sami Closes $18M Series B and NEXT Life Sciences Raises Seed Round
Two StartUp Health companies — Sami and NEXT Life Sciences — closed funding rounds this week to support Brazilian healthcare and male contraception.
NEXT Life Sciences Raises $1.55M for Plan A, Its Male Contraceptive
NEXT Life Sciences is set to revolutionize contraception with Plan A, a safe, effective, and reversible birth control method for men. Responding to the growing demand for male contraceptives, NEXT aims to initiate clinical trials by the end of 2023.
$1.55M Raised for Plan A™ Male Birth Control Product, Seeking Clinical Trials in 2023
After years in development by the Parsemus Foundation, NEXT Life Sciences, Inc. has announced its plans to bring a new contraceptive product to market through Plan A™ – a safe, effective, reversible birth control for men.